S0003981

NxTekEliminateMalPfNonSafetyLanc,kit/25


This material replaces the material S0003858 Alere Mal AgPf wnonsafety lancet,25T/kit. But the product itself remains the same.
Indicative Price 7.50 USD
Disclaimer: The images shown are for illustration purposes only and may not be an exact representation of the product. “No Generic Photo Available" means that there is not an image available for this product.

General description:
The NxTek Eliminate Malaria Pf is an ultra-sensitive, qualitative in vitro test for the detection of histidine rich protein 2 (HRP2) antigen of Plasmodium falciparum malaria in human whole blood. The test is intended for professional use and the point-of-care testing to aid in the diagnosis of malaria infection to a general population including pregnant women.

Technical specifications:
Technology: Lateral immuno-chromatographic test
Format: Cassette, 25 tests
Sample type: Whole blood
Sample volume: 5µl
Pf panel detection score: 98.0%
False positive rate: 0.9%
Invalidity rate: 0.1%
Reading time: 20 mins

Manufacturer product reference: Abbott Diagnostics Korea Inc., 05FK140

Items supplied with:
·Test device with a desiccant in individual foil pouch, 25
·Assay diluent vial (5ml), 1
·Disposable inverted cup, 25
·Alcohol swab, 25
·Sterile non-safety lancet, 25
·Instruction for use, 1

Items required, but not supplied:
Disposable gloves, timer, container for biohazard disposables, pen/pencil, sterile gauze, if collection by venipuncture: Venipuncture blood collection tube, micropipette, pipette tips

Shelf life:
12 months from the date of manufacturing; do not use beyond its expiry date.

Weight and Volume:
Estimated weight: 0.31 kg
Estimated volume: 1.0138 dm3

Storage and transportation condition:
Between 1 to 30°C, protect against humidity and direct sunlight. Do not freeze reagents.

Packaging and labeling:
Primary packaging: All contents of NxTek Eliminate Malaria Pf wnonsafetylancet, kit for 25 tests
Secondary packaging: One kit NxTek Eliminate Malaria Pf wnonsafetylancet, 25 tests

General recommendations:
·For guidance on selection criteria for procurement of mRDTs,
·Public reports of WHO prequalified in vitro diagnostic products
·Follow strictly manufacturer instructions for use of the test procedure (especially adherence to reading time).
Related Products